Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
Abbott LaboratoriesABT |
-$190,000 | |
HCA HealthcareHCA |
-$57,000 | |
Waters CorporationWAT |
-$8,000 | |
Cardinal HealthCAH |
$91,000 | |
Henry ScheinHSIC |
-$40,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Rohit Khanna Democrat | Apr 26, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | Oct 2, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Aug 29, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Jul 12, 2023 | Sell | $15K - $50K |
Daniel S. Goldman Democrat | Apr 10, 2023 | Buy | $15K - $50K |
Suzanne Lee Democrat | Nov 30, 2022 | Sell | $1K - $15K |
Who is the latest politician to buy or sell Teleflex shares?
Rohit Khanna purchased Teleflex shares most recently on April 26, 2024.
Which politician has bought the most TFX stock in the last two years?
Daniel S. Goldman has bought the most TFX stock in the last 2 years, with an estimated value of $33,000.
Which politician has sold the most TFX stock over the last two years?
Daniel S. Goldman has sold the most TFX stock in the last 2 years, with an estimated value of $33,000.
What is the total value of politicians trading TFX stock in the last 2 years?
There have been no US politicians buying or selling Teleflex in the last 2 years.
How do insider transactions over the last 2 years reflect on Teleflex's market confidence?
Over the last 2 years, insider transactions for Teleflex have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.